About INCOG BioPharma Services
INCOG BioPharma Services is a company based in United States founded in 2020 by Cory Lewis and Tedd Green. INCOG BioPharma Services has raised $86.63 million across 5 funding rounds. INCOG BioPharma Services offers products and services including Drug Development Services, Manufacturing Services, and Analytical and Quality Control. INCOG BioPharma Services operates in a competitive market with competitors including Gland Pharma, Exela Pharma, Luoxin Pharmaceutical Group, Summit Biosciences and ApiJect, among others.
- Headquarter United States
- Founders Cory Lewis, Tedd Green
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Incog Biopharma Services, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$86.63 M (USD)
in 5 rounds
-
Latest Funding Round
$42.86 M (USD), Series C
May 14, 2024
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of INCOG BioPharma Services
INCOG BioPharma Services offers a comprehensive portfolio of products and services, including Drug Development Services, Manufacturing Services, and Analytical and Quality Control.
Assists in developing injectable drug products for market acceleration
Manufactures injectable drugs using advanced facilities and quality controls
Provides testing for drug safety and compliance in pharmaceutical processes
Funding Insights of INCOG BioPharma Services
INCOG BioPharma Services has successfully raised a total of $86.63M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $42.86 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by INCOG BioPharma Services
Investment portfolio details for INCOG BioPharma Services
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - INCOG BioPharma Services
Detailed financials for INCOG BioPharma Services
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Incog Biopharma Services Comparisons
Peer comparison for INCOG BioPharma Services
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of INCOG BioPharma Services
INCOG BioPharma Services operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gland Pharma, Exela Pharma, Luoxin Pharmaceutical Group, Summit Biosciences and ApiJect, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Generic injectable drugs are manufactured across therapeutic segments.
|
|
| Locked | Locked | Locked |
Sterile injectable pharmaceuticals are manufactured alongside CDMO services.
|
|
| Locked | Locked | Locked |
Developer and manufacturer of pharmaceutical products
|
|
| Locked | Locked | Locked |
Nasal spray drug products are developed, manufactured, and commercialized.
|
|
| Locked | Locked | Locked |
Medicine injectors are manufactured by ApiJect for medical applications.
|
|
| Locked | Locked | Locked |
Diversified research services for clinical solutions are offered.
|
Detailed competitors of INCOG BioPharma Services
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Incog Biopharma Services
Complete news archive for INCOG BioPharma Services
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about INCOG BioPharma Services
INCOG BioPharma Services was founded in 2020.
INCOG BioPharma Services is headquartered in United States.
Cory Lewis is the current CEO of INCOG BioPharma Services. They have also founded this company.
INCOG BioPharma Services is a funded company, having raised a total of $86.63M across 5 funding rounds to date.
INCOG BioPharma Services was founded in 2020 in the United States as a contract development and manufacturing organization. Emphasis is placed on the production of injectable drug products within the biopharmaceutical sector. Services encompass drug product manufacturing for clients, with operations based domestically. The company was co-founded by Cory Lewis, serving as CEO, and Tedd Green, serving as COO, supporting pharmaceutical development needs.
INCOG BioPharma Services's top competitors include Exela Pharma, Gland Pharma and Luoxin Pharmaceutical Group.
INCOG BioPharma Services offers Drug Development Services, Manufacturing Services, and Analytical and Quality Control.